Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Treatment of Major Depression, Tryptophan and brain disorders, Bipolar Disorder and Treatment, and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes.
Biological insights into schizophrenia from ancestrally diverse populations
Biological Insights from Schizophrenia-associated Loci in Ancestral Populations
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators
Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial
Longitudinal study of inflammation and relapse in schizophrenia
Rare coding variants in ten genes confer substantial risk for schizophrenia
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation
Prognostic value of polygenic risk scores for adults with psychosis
Transcutaneous Cervical Vagal Nerve Stimulation in Patients with Posttraumatic Stress Disorder (PTSD): A Pilot Study of Effects on PTSD Symptoms and Interleukin-6 Response to Stress
A novel peripheral biomarker for depression and antidepressant response
Psychiatry's modern role in functional neurological disorder: join the renaissance
Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders
Diet, Stress and Mental Health
Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans
Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts
Treatment of functional neurological disorder: current state, future directions, and a research agenda
Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon-γ in posttraumatic stress disorder: A double-blind, randomized, sham-controlled trial
Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry
Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases
Massage Therapy for Psychiatric Disorders
Contribution of rare copy number variants to bipolar disorder risk is limited to schizoaffective cases
Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
Massage therapy decreases cancer‐related fatigue: Results from a randomized early phase trial
Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings
Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future